Stock Market News for March 3, 2026
765 news published.
Market moves & capital raises
Vertiv (VRT) completed a $2.1 billion senior unsecured bond offering and secured a $2.5 billion revolving credit facility, shoring up liquidity for capacity expansion and R&D as demand for data-center infrastructure remains strong; offering details here.
The Michaels Companies (MIK) priced a tender offer for its 7.875% senior notes due 2029, a debt-refinancing move that could lower interest expense and improve covenant flexibility; notice here.
Dave (DAVE) unveiled a proposed offering of convertible notes, a capital-raising step that investors will weigh for dilution risk versus bolstering the balance sheet for growth; filing here.
Corporate moves, settlements & strategic transactions
Genevant Sciences and Arbutus Biopharma reached a $2.25 billion global settlement with Moderna over patent disputes, resolving a high-profile litigation cloud that had implications for royalties and biotech IP valuations; company release here. Related Roivant commentary ties the deal into broader corporate positioning for partnered assets.
Honeywell (HON)'s planned spin of Honeywell Aerospace remains a structural theme for industrials; investors watch separation progress as a potential valuation catalyst—filing here.
Diamond Hill (DHIL) won shareholder approvalhere.
Earnings, results and company updates
Accel Entertainment (ACEL) reported record Q4 with a 7.5% revenue increase and full-year revenue of $1.3 billion, a beat that supports gaming-operator growth narratives and cash-flow leverage; release here.
AutoZone (AZO) and Ross Stores (ROST) remain on investors' radars after strong quarterly prints; these consumer staples and discretionary reads continue to inform sector rotation and retail margin expectations (AutoZone, Ross).
Target (TGT) laid out a strategic plan for 2026 and beyond, offering investors a roadmap for growth, margin recovery and market share defenses that could reshape expectations for retail peers; strategy note here.
Calendar items & upcoming results
Smithfield Foods (SFD) set its Q4 and FY2025 results release for March 24, a date investors in packaged foods and margins should note for earnings-season guidance; announcement here.
Sleep Number (SNBR) will report Q4 and FY2025 results on March 12, an item for consumer-discretionary watchers tracking housing-related furniture demand; release here.
Titan America (TTAM) scheduled Q4 and FY2025 results for March 17, a calendar cue for construction-materials investors; notice here.
Tech, semiconductors & AI infrastructure
Micron (MU) announced the first 256GB LPDRAM SOCAMM2 for data centers, a product milestone that speaks to memory suppliers' role in scaling AI workloads and server density; product note here.
Tempus (TEM) and CrowdStrike (CRWD)'s results continue to highlight how AI and security are reshaping enterprise spend—key signals for software valuation and ARR multiples (Tempus, CrowdStrike).
Healthcare, biotech & clinical updates
Theravance Biopharma (TBPH) confirmed its Phase 3 CYPRESS miss and launched a strategic review with cost cuts, a setback that often forces pipeline reprioritization and increases M&A or partnering odds; release here.
Vanda Pharmaceuticals (VNDA) received an FDA hearing for HETLIOZ® in jet lag disorder, a regulatory event that could change labeling or access in a space without major competition—announcement here.
Filings, distributions & corporate housekeeping
Horizon Technology Finance (HRZN) released monthly distributions totaling $0.18 per share for April–June 2026 and filed Q4 results, items that matter for yield-focused investors and BDC cash-flow modeling; notices here and here.
Blue Hat (BHAT) and TIAN RUIXIANG (TIRX) remain on the radar after reverse splits were announced—moves that affect liquidity and index eligibility and warrant close attention ahead of effective dates (Blue Hat, TIAN RUIXIANG).
Market data & macro flows
CME Group (CME) set a monthly ADV record of 37.6 million contracts in February, signaling heightened derivatives activity that typically boosts trading revenues and volatility-linked flows; release here.
Selective corporate & sector updates
Regional Management (RM) partnered with Column N.A. on new lending capacity to support growth and risk-adjusted returns, a development meaningful for specialty-finance names scaling origination platforms; announcement here.
Small- and mid-cap earnings continue to roll in—names like Cricut (CRCT), Quantum-Si (QSI) and others are being triaged by investors for revenue trends, guidance and cash metrics; see individual releases for detail.
Stay ahead of the market with our list of today's most important stock news and financial updates. Whether you're a day trader, long-term investor, or market enthusiast, our news feed covers everything you need to know about publicly traded companies.
Our news feed is designed for investors who want to stay informed about the latest developments affecting their portfolio or watchlist. Whether you're researching potential investments, monitoring your current holdings, or simply staying up-to-date with market trends, our stock news page provides the information you need to make informed decisions.
What You'll Find on This Page:
- Breaking financial news and market-moving headlines
- FDA approvals and clinical trial results for biotech and pharma stocks
- Stock offerings, dividends, and other corporate actions
- Mergers, acquisitions, and strategic partnerships
- Business news affecting company performance and stock prices
- Easy-to-use tags for quick news categorization
- Stock tickers for instant company identification
- AI sentiment analysis to gauge market reaction
- Estimated impact scores to assess potential stock movement